163 related articles for article (PubMed ID: 10378705)
21. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.
Kosinski M; Kujawski SC; Martin R; Wanke LA; Buatti MC; Ware JE; Perfetto EM
Am J Manag Care; 2002 Mar; 8(3):231-40. PubMed ID: 11915973
[TBL] [Abstract][Full Text] [Related]
22. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.
Li Z; An Y; Su H; Li X; Xu J; Zheng Y; Li G; Kwok K; Wang L; Wu Q
Int J Rheum Dis; 2018 Feb; 21(2):402-414. PubMed ID: 29314645
[TBL] [Abstract][Full Text] [Related]
23. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
[TBL] [Abstract][Full Text] [Related]
24. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
[TBL] [Abstract][Full Text] [Related]
26. Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis.
Cohen JD; Dougados M; Goupille P; Cantagrel A; Meyer O; Sibilia J; Daurès JP; Combe B
J Rheumatol; 2006 Oct; 33(10):1936-41. PubMed ID: 16924692
[TBL] [Abstract][Full Text] [Related]
27. Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial.
Naqvi AA; Hassali MA; Naqvi SBS; Aftab MT
Trials; 2019 Aug; 20(1):488. PubMed ID: 31399128
[TBL] [Abstract][Full Text] [Related]
28. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
29. Effects of a modular behavioural arthritis education programme: a pragmatic parallel-group randomized controlled trial.
Hammond A; Bryan J; Hardy A
Rheumatology (Oxford); 2008 Nov; 47(11):1712-8. PubMed ID: 18815153
[TBL] [Abstract][Full Text] [Related]
30. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
[TBL] [Abstract][Full Text] [Related]
31. Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial.
Masiero S; Boniolo A; Wassermann L; Machiedo H; Volante D; Punzi L
Clin Rheumatol; 2007 Dec; 26(12):2043-2050. PubMed ID: 17404783
[TBL] [Abstract][Full Text] [Related]
32. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
Rigby W; Ferraccioli G; Greenwald M; Zazueta-Montiel B; Fleischmann R; Wassenberg S; Ogale S; Armstrong G; Jahreis A; Burke L; Mela C; Chen A
Arthritis Care Res (Hoboken); 2011 May; 63(5):711-20. PubMed ID: 21557525
[TBL] [Abstract][Full Text] [Related]
33. Brazil Patient Knowledge Questionnaire (PKQ) and evaluation of disease-specific knowledge in patients with rheumatoid arthritis.
Jennings F; Toffolo S; de Assis MR; Natour J
Clin Exp Rheumatol; 2006; 24(5):521-8. PubMed ID: 17181920
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
[TBL] [Abstract][Full Text] [Related]
35. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
Schiff MH; Yu EB; Weinblatt ME; Moreland LW; Genovese MC; White B; Singh A; Chon Y; Woolley JM
Drugs Aging; 2006; 23(2):167-78. PubMed ID: 16536638
[TBL] [Abstract][Full Text] [Related]
36. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.
Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S126-35. PubMed ID: 18240203
[TBL] [Abstract][Full Text] [Related]
37. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis.
Brus HL; van de Laar MA; Taal E; Rasker JJ; Wiegman O
Ann Rheum Dis; 1998 Mar; 57(3):146-51. PubMed ID: 9640129
[TBL] [Abstract][Full Text] [Related]
38. Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.
Kuusalo L; Puolakka K; Kautiainen H; Karjalainen A; Malmi T; Yli-Kerttula T; Leirisalo-Repo M; Rantalaiho V;
Rheumatol Int; 2017 May; 37(5):825-830. PubMed ID: 28289873
[TBL] [Abstract][Full Text] [Related]
39. The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis.
Hammond A; Freeman K
Clin Rehabil; 2004 Aug; 18(5):520-8. PubMed ID: 15293486
[TBL] [Abstract][Full Text] [Related]
40. Automated joint space width quantification of hand and wrist joints: a proof of concept study.
Huo Y; Veldhuizen RD; van der Heijde DM; Besselink NJ; Jacobs JW; van Laar JM; Viergever MA; Vincken KL; Lafeber FP; de Hair MJ;
Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S34-S39. PubMed ID: 27762190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
